Ronald B. Stark - 04 Jan 2024 Form 4 Insider Report for Livent Corp.

Role: Chief Accounting Officer
Signature: /s/ Sara Ponessa, as attorney-in-fact
Issuer symbol: N/A
Transactions as of: 04 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 08 Jan 2024, 16:04:11 UTC
Previous filing: 27 Dec 2023
Next filing: 01 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LTHM	Common Stock	Disposed to Issuer		-13,018	-100%		0	04 Jan 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Shares	Change %	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LTHM	Stock Option (Right to Buy)	Disposed to Issuer	-2,983	-100%	04 Jan 2024	Common Stock	2,983	$23.33	Direct	F2
transaction	LTHM	Stock Option (Right to Buy)	Disposed to Issuer	-3,210	-100%	04 Jan 2024	Common Stock	3,210	$21.01	Direct	F2
transaction	LTHM	Stock Option (Right to Buy)	Disposed to Issuer	-12,185	-100%	04 Jan 2024	Common Stock	12,185	$20.35	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ronald B. Stark is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Represents the conversion of common stock and restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares and restricted stock units with respect to ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction.
F2	Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction.

Content

Represents the conversion of common stock and restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares and restricted stock units with respect to ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction.

Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction.